91�鶹����

Media Contact: dkenney@mbl.edu; 508-685-3525

WOODS HOLE, Mass. —A team at the Marine Biological Laboratory (MBL) has achieved the first gene knockout in a cephalopod using the squid Doryteuthis pealeii, an exceptionally important research organism in biology for nearly a century. The milestone study, led by 91�鶹���� scientists Joshua Rosenthal and , is reported in the July 30 issue of .

The team used CRISPR-Cas9 genome editing to knock out a pigmentation gene in squid embryos, which eliminated pigmentation in the eye and in skin cells (chromatophores) with high efficiency.

“This is a critical first step toward the ability to knock out -- and knock in -- genes in cephalopods to address a host of biological questions,” Rosenthal says.

Longfin inshore squid (Doryteuthis pealeii) hatchlings. On the left is a control hatchling; note the black and reddish brown chromatophores evenly placed across its mantle, head and tentacles.
In contrast, the embryo on the right was injected with CRISPR-Cas9 targeting a pigmentation gene (Tryptophan 2,3 Dioxygenase) before the first cell division ; it has very few pigmented chromatophores and light pink to red eyes. Credit: Karen Crawford

Rosenthal is a senior scientist in the MBL’s Eugene Bell Center for Regenerative Biology and Tissue Engineering. Crawford is a professor of biology at St. Mary’s College of Maryland and a Whitman Center investigator at the MBL.

Cephalopods (squid, octopus and cuttlefish) have the largest brain of all invertebrates, a distributed nervous system capable of instantaneous camouflage and sophisticated behaviors, a unique body plan, and the ability to extensively recode their own genetic information within messenger RNA, along with other distinctive features. These open many avenues for study and have applications in a wide range of fields, from evolution and development, to medicine, robotics, materials science, and artificial intelligence.

The ability to knock out a gene to test its function is an important step in developing cephalopods as genetically tractable organisms for biological research, augmenting the handful of species that currently dominate genetic studies, such as fruit flies, zebrafish, and mice.

It is also a necessary step toward having the capacity to knock in genes that facilitate research, such as genes that encode fluorescent proteins that can be imaged to track neural activity or other dynamic processes.

“CRISPR-Cas9 worked really well in Doryteuthis; it was surprisingly efficient,” Rosenthal says. Much more challenging was delivering the CRISPR-Cas system into the one-celled squid embryo, which is surrounded by an exceedingly tough outer layer, and then raising the embryo through hatching. The team developed micro-scissors to clip the egg’s surface and a beveled quartz needle to deliver the CRISPR-Cas9 reagents through the clip.

Studies with Doryteuthis pealeii have led to foundational advances in neurobiology, beginning with description of the action potential (nerve impulse) in the 1950s, a discovery for which Alan Hodgkin and Andrew Huxley became Nobel Prize laureates in 1963. For decades D. pealeii has drawn neurobiologists from all over the world to the MBL, which collects the squid from local waters.

Doryteuthis pealeii, often called the Woods Hole squid. Studies with D. pealeii have led to major advances in neurobiology, including description of the fundamental mechanisms of neurotransmission. 91�鶹���� collects D. pealeii from local waters for an international community of researchers. Credit: Roger Hanlon

Recently, Rosenthal and colleagues discovered extensive recoding of mRNA in the nervous system of �ٴǰ���ٱ�ܳٳ󾱲���and other cephalopods. This research is under development for potential biomedical applications, such as pain management therapy.

D. pealeii is not, however, an ideal species to develop as a genetic research organism. It’s big and takes up a lot of tank space plus, more importantly, no one has been able to culture it through multiple generations in the lab.

For these reasons, the MBL Cephalopod Program’s next goal is to transfer the new knockout technology to a smaller cephalopod species, Euprymna berryi (the hummingbird bobtail squid), which is relatively easy to culture to make genetic strains.

The MBL Cephalopod Program is part of the MBL’s New Research Organisms Initiative, which is widening the palette of genetically tractable organisms available for research – and thus expanding the universe of biological questions that can be asked.

Ring of mosaic squid hatchlings (Doryteuthis pealeii). These embryos were injected with CRISPR-Cas9 at different times before the first cell division, resulting in mosaic embryos with different degrees of knockout. Credit: Karen Crawford

Citation:

Karen Crawford, Juan F. Diaz Quiroz, Kristen M. Koenig, Namrata Ahuja, Caroline B. Albertin, and Joshua J.C. Rosenthal (2020) .��Current Biology, DOI: 10.1016/j.cub.2020.06.099

Homepage photo: Squid embryo at hatching with pigmentation gene knocked out. Credit: Karen Crawford

—###—

The Marine Biological Laboratory (MBL) is dedicated to scientific discovery – exploring fundamental biology, understanding marine biodiversity and the environment, and informing the human condition through research and education. Founded in Woods Hole, Massachusetts in 1888, the MBL is a private, nonprofit institution and an affiliate of the .